Detection of perimenopause or postmenopause human chorionic gonadotropin: an unnecessary source of alarm

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 3, 2008, Pages 275.e1-275.e7

  Cole, Laurence A ^a   Khanlian, Sarah A ^a   Muller, Carolyn Y ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

human chorionic gonadotropin; menopause; perimenopause; pituitary

Indexed keywords

CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE;

ADULT; AGED; ARTICLE; CLIMACTERIUM; CLINICAL ARTICLE; FEMALE; GONADOTROPIN BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS; KIDNEY TRANSPLANTATION; LUTEINIZING HORMONE BLOOD LEVEL; MENOPAUSE; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RECURRENT DISEASE; TROPHOBLASTIC DISEASE;

EID: 39649100193     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.09.034     Document Type: Article

References (28)

1. Chen H.C., Hodgen G.D., Matsuura S., et al. Evidence for a gonadotropin from non-pregnant subjects that has physical, immunological and biological similarities to human chorionic gonadotropin. Proc Natl Acad Sci 73 (1976) 2885-2889
2. Matsuura S., Ohashi M., Chen H.C., et al. Physicochemical and immunological characterization of an hCG-like substance from human pituitary glands. Nature 286 (1980) 740-741
3. Huang S.C., Chen H.C., Chen R.J., Hsieh C.Y., Wei P.Y., and Ouyang P.C. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures. J Clin Endocrinol Metab 58 (1984) 646-653
4. Wahlstrom T., Stenman U.H., Lundqvist C., Tanner P., Schroder J., and Seppala M. The use of monoclonal antibodies against human chorionic gonadotropin for immunoperoxidase staining of normal placenta, pituitary gland, and pituitary adenomas. J Histochem Cytochem 29 (1981) 864-865
5. Seki K., Matsui H., and Sekiya S. Advances in the clinical laboratory detection of gestational trophoblastic disease. Clinica Chimica Acta 349 (2004) 1-13
6. Cole L.A., and Khanlian S.A. Inappropriate management of women with persistent low hCG results. J Reprod Med 49 (2004) 423-432
7. Birken S., Maydelman Y., Gawinowicz M.A., Pound A., Liu Y., and Hartree A.S. Isolation and characterization of human pituitary chorionic gonadotropin. Endocrinol 137 (1996) 1402-1411
8. Hoermann R., Spoettl G., Moncayo R., and Mann K. Evidence for the presence of human chorionic gonadotropin (hCG) and free beta-subunit of hCG in the human pituitary. J Clin Endocrinol Metab 71 (1990) 179-186
9. Snyder J.A., Haymond S., Parvin C.A., Gronowski A.M., and Grenache D.G. Diagnostic considerations in the measurement of human chorionic gonadotropin in aging women. Clin Chem 51 (2005) 1830-1835
10. Armstrong E.G., Ehrlich P.H., Birken S., et al. Use of a highly sensitive and specific immunoradiometric assay for detection of human chorionic gonadotropin in urine of normal, non-pregnant and pregnant individuals. J Clin Endocrinol Metab 59 (1984) 867-874
11. Akar A.H., Gervasi G., Blacker C., Wehmann R.E., Blithe D.L., and Nisula B.C. Human chorionic gonadotropin-like and β-core like materials in postmenopausal urine. J Endocrinol 125 (1990) 477-484
12. Braunstein G.D., Kamdar V., Rasor J., Swaminathan N., and Wade M.E. Widespread distribution of a chorionic gonadotropin-like substance in normal human tissues. J Clin Endocrinol Metab 49 (1979) 917-925
13. Wahlstrom T., Stenman U.H., Lundqvist C., Tanner P., Schroder J., and Seppala M. The use of monoclonal antibodies against human chorionic gonadotropin for immunoperoxidase staining of normal placenta, pituitary gland, and pituitary adenomas. J Histochem Cytochem 29 (1981) 864-865
14. O'Connor J., Birken S., Lustbader J.W., Krichevsky A., Chen Y., and Canfield R.E. Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements. Endocr Rev 15 (1994) 650-683
15. Hartree A.S., Shownkeen R.C., Stevens V.C., Matsuura S., Ohashi M., and Chen H.C. Studies of the human chorionic gonadotrophin-like substance of human pituitary glands and its significance. J Endocrinol 96 (1983) 115-126
16. Cole L.A., Khanlian S.A., Sasaki Y., and Muller C.Y. Normal production of hCG in menopause: a medical management dilemma. N Eng J Med 356 (2007) 1184-1186
17. Cole L.A. Background hCG in healthy non-pregnant women. Clin Chem 51 (2005) 1765-1766
18. Cole L.A., Khanlian S.A., Muller C.Y., Giddings A., Kohorn E.I., and Berkowitz R. Gestational trophoblastic diseases: 3, human chorionic gonadotropin free β-subunit a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 102 (2006) 159-163
19. Cole L.A., Khanlian S.A., Giddings A., et al. Gestational trophoblastic diseases: 4, presentation with persistent low positive human chorionic gonadotropin. Gynecol Oncol 102 (2006) 164-171
20. Louhimo J., Kokkola A., Alfthan H., Stenman U.H., and Haglund C. Preoperative hCGβ and CA 72-4 are prognostic factors in gastric cancer. Intl J Cancer 111 (2004) 929-933
21. Carpelan-Holmstrom M., Louhimo J., Stenman U.H., Alfthan H., Jarvinen H., and Haglund C. Estimating the probability of cancer with several tumor markers in patients with colorectal disease. Oncol 66 (2004) 296-302
22. Louhimo J., Alfthan H., Stenman U.H., and Haglund C. Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer. Oncol 66 (2004) 126-131
23. Hotakainen K., Haglund C., Paju A., et al. Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue. Eur Urol 41 (2002) 677-685
24. Hotakainen K., Ljungberg B., Paju A., Rasmuson T., Alfthan H., and Stenman U.H. The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma. Br J Cancer 86 (2002) 185-189
25. Cole L.A., and Sutton J.M. Selecting an appropriate hCG test for management of gestational trophoblastic diseases and cancer cases. J Reprod Med 49 (2004) 545-553
26. Cole L.A., Butler S.A., Khanlian S.A., et al. Gestational trophoblastic diseases: 2, hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecol Oncol 102 (2006) 150-158
27. Cole L.A. Human chorionic gonadotropin (hCG), free α (free α), free β (free β) and β-core fragment (β-core). Diagn Endocrinol Metab 15 (1997) 199-220
28. Birken S., Kovalevskaya G., and O'Connor J. Metabolism of hCG and hLH to multiple urinary forms. Molec Cellul Endocrinol 125 (1996) 121-131